Blood-based monitoring identifies acquired and targetable driver HER2 mutations in endocrine-resistant metastatic breast cancerArielle J. Medford, Aditya Bardia, Andrzej Niemierko et al.|npj Precision Oncology|2019Cited by 30
Identification of Somatically Acquired <i>BRCA1/2</i> Mutations by cfDNA Analysis in Patients with Metastatic Breast CancerNeelima Vidula, Aditya Bardia, Taronish D. Dubash et al.|Clinical Cancer Research|2020Cited by 24